The Shared Genetic Basis of Hyperuricemia, Gout, and Kidney Function

Area of Science:

• Genetics
• Nephrology
• Metabolic Diseases

Background:

• Elevated serum urate levels and gout are associated with chronic kidney disease (CKD).
• Reduced kidney function is considered the primary driver of this relationship.
• Genome-wide association studies (GWAS) suggest a more complex genetic correlation between serum urate and kidney function.

Purpose of the Study:

• To investigate the shared genetic architecture between serum urate levels and kidney function.
• To explore potential molecular mechanisms underlying the observed genetic overlap.
• To identify novel pathways involved in the pathogenesis of hyperuricemia/gout and CKD.

Main Methods:

• Comparative analysis of GWAS results for serum urate levels and kidney function.
• Identification and characterization of shared genetic loci.
• Investigation of candidate genes and pathways implicated in shared loci.

Main Results:

• Approximately 20% of genetic loci associated with serum urate levels are also associated with kidney function.
• Shared loci do not primarily involve urate transporters, suggesting alternative mechanisms.
• Notable loci include ATXN2 (implicating chromatin regulation and systemic metabolism) and HNF4A (showing genetic heterogeneity).
• A significant enrichment of shared loci was observed in the olfactory receptor pathway.

Conclusions:

• The genetic relationship between serum urate and kidney function is more intricate than previously understood.
• Systemic metabolic alterations and novel genetic pathways, beyond urate transport, contribute to the comorbidity of hyperuricemia/gout and CKD.
• GWAS have generated testable hypotheses for understanding the shared pathogenesis of these conditions.